<DOC>
	<DOC>NCT02384629</DOC>
	<brief_summary>1. To compare the safety and efficacy of AXXESS stent with conventional DES in patients with coronary artery bifurcation disease 2. To assess the impact of optical coherence tomography (OCT) guidance on clinical outcomes following the stent type</brief_summary>
	<brief_title>PCI With AXXESS Biolimus A9 Eluting Bifurcation Stent in Treating Coronary Artery Bifurcation Disease</brief_title>
	<detailed_description />
	<criteria>Provision of informed consent prior to any study specific procedures, Patients â‰¥ 19 years old, Patients who are expected to undergo PCI for bifurcation lesions. Age&gt; 85 years, Cardiogenic shock or unstable patients, Increased risk of bleeding, anemia, thrombocytopenia, A need for oral anticoagulation therapy, Pregnant women or women with potential childbearing, Life expectancy &lt; 1 year.</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>July 2016</verification_date>
</DOC>